In a filing, Solid Biosciences Inc revealed its Director Kahn Clare acquired Company’s shares for reported $9924.0 on Mar 11 ’25. In the deal valued at $5.34 per share,1,860 shares were bought. As a result of this transaction, Kahn Clare now holds 2,960 shares worth roughly $15066.4.
Then, Bain Capital Life Sciences Inv bought 1,000,000 shares, generating $4,030,000 in total proceeds. Upon buying the shares at $4.03, the 10% Owner now owns 5,034,582 shares.
Before that, PERCEPTIVE ADVISORS LLC bought 5,000,000 shares. Solid Biosciences Inc shares valued at $20,150,000 were divested by the Director at a price of $4.03 per share. As a result of the transaction, PERCEPTIVE ADVISORS LLC now holds 11,833,539 shares, worth roughly $60.23 million.
Truist initiated its Solid Biosciences Inc [SLDB] rating to a Buy in a research note published on January 08, 2025; the price target was $16. A number of analysts have revised their coverage, including Wedbush’s analysts, who began to cover the stock in mid December with a ‘”an Outperform”‘ rating. JMP Securities began covering SLDB with “Mkt outperform” recommendation on December 10, 2024. JP Morgan revised its rating on July 15, 2024. It rated SLDB as “an Overweight” which previously was an “a Neutral”.
Price Performance Review of SLDB
On Friday, Solid Biosciences Inc [NASDAQ:SLDB] saw its stock fall -1.07% to $5.09. Over the last five days, the stock has lost -6.09%. Solid Biosciences Inc shares have risen nearly 27.25% since the year began. Nevertheless, the stocks have fallen -55.35% over the past one year. While a 52-week high of $15.05 was reached on 02/18/25, a 52-week low of $2.88 was recorded on 02/07/25. SMA at 50 days reached $4.21, while 200 days put it at $6.22.
Levels Of Support And Resistance For SLDB Stock
The 24-hour chart illustrates a support level at 4.95, which if violated will result in even more drops to 4.81. On the upside, there is a resistance level at 5.27. A further resistance level may holdings at 5.45. The Relative Strength Index (RSI) on the 14-day chart is 51.62, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.06, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 67.23%. Stochastics %K at 45.86% indicates the stock is a holding.
How much short interest is there in Solid Biosciences Inc?
A steep rise in short interest was recorded in Solid Biosciences Inc stocks on 2025-02-28, growing by 4.67 million shares to a total of 7.32 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 2.65 million shares. There was a rise of 63.78%, which implies that there is a positive sentiment for the stock.
